Core Insights - Chengdu Bornsi Medical Robotics Co., Ltd. has successfully developed China's first transoral robotic surgery system (TORSS), marking a significant milestone in the domestic surgical robot industry [1][2] - The company aims to expand its market presence internationally, with India identified as the first target due to its large population and a medical market exceeding $200 billion [2] Company Development - Founded in 2016 by Li Yao, a scientist from Stanford University, the company focuses on the research and development of domestic surgical robots [1] - The company achieved a breakthrough on October 29, when its surgical robot completed the world's first specialized transoral surgery for early laryngeal cancer at Fudan University’s affiliated Ear, Nose, and Throat Hospital [1] Market Expansion - The company has successfully entered the Indian market after extensive efforts, including visiting hospitals and doctors for nine months, leading to a partnership with MAX Hospital, India's largest private healthcare group [2] - The rapid acceptance of the robot in the Indian medical community has opened up significant growth opportunities for the company [2] Financial Support - To support its expansion, the company received a 10 million yuan "Sci-tech Loan" from Industrial Bank, facilitated by the Chengdu Productivity Promotion Center, which helps address the financing needs of technology enterprises [2] - The loan was secured against the company's intellectual property, highlighting the importance of converting intellectual property into assets for tech companies [2]
为梦奔跑的2024③|李耀:两年飞了320次,让“成都造”手术机器人走向海外